Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Terns Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- 0 vs. Q1 2022
- Shares held
- 14.7M
- −2.09M (−12.4%) vs. Q1 2022
- Total value
- $36.5M
- −$13.5M (−27.0%) vs. Q1 2022
- New holders
- 13
- 11 more added
- Sold out
- 13
- 13 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| New York State Common Retirement Fund | 118 | $0 | 0.00% | −5,800−98.0% | Reduced |
| Wells Fargo & Company | 52 | $0 | 0.00% | −561−91.5% | Reduced |
| Credit Suisse AG | 7 | $0 | 0.00% | +7 | New |
| Capital Advisors, Ltd. LLC | 102 | $0 | 0.00% | +102 | New |
| Citigroup Inc | 519 | $1.00K | 0.00% | −548−51.4% | Reduced |
| JPMorgan Chase & Co | 963 | $2.00K | 0.00% | −8,404−89.7% | Reduced |
| Cubist Systematic Strategies, LLC | 2,428 | $6.00K | 0.00% | +1,228+102.3% | Added |
| Tower Research Capital LLC (TRC) | 10,480 | $26.0K | 0.00% | +6,924+194.7% | Added |
| Qube Research & Technologies Ltd | 11,408 | $28.0K | 0.00% | +11,408 | New |
| Acadian Asset Management LLC | 12,627 | $31.0K | 0.00% | +12,627 | New |
| Barclays PLC | 13,125 | $33.0K | 0.00% | −2,227−14.5% | Reduced |
| Northern Trust Corp | 14,373 | $36.0K | 0.00% | −90,449−86.3% | Reduced |
| Goldman Sachs Group Inc | 16,588 | $41.0K | 0.00% | +161+1.0% | Added |
| Bank of America Corp | 18,108 | $45.0K | 0.00% | +10,884+150.7% | Added |
| Morgan Stanley | 18,671 | $46.0K | 0.00% | +10,180+119.9% | Added |
| State Street Corp | 19,837 | $49.0K | 0.00% | −143,400−87.8% | Reduced |
| Bailard, Inc. | 20,300 | $50.0K | 0.00% | +20,300 | New |
| Citadel Advisors LLC | 38,810 | $96.0K | 0.00% | +38,810 | New |
| Bridgeway Capital Management, LLC | 45,500 | $113.0K | 0.00% | −17,200−27.4% | Reduced |
| Marquette Asset Management, LLC | 57,876 | $144.0K | 0.04% | +36,074+165.5% | Added |
| Ergoteles LLC | 63,454 | $157.0K | 0.00% | +63,454 | New |
| Geode Capital Management, LLC | 79,324 | $196.0K | 0.00% | −99,987−55.8% | Reduced |
| Caas Capital Management LP | 97,512 | $242.0K | 0.03% | +11,661+13.6% | Added |
| FMR LLC | 101,675 | $252.0K | 0.00% | −2,219,783−95.6% | Reduced |
| Boothbay Fund Management, LLC | 106,712 | $265.0K | 0.01% | +106,712 | New |
| BlackRock Inc. | 149,528 | $371.0K | 0.00% | −587,413−79.7% | Reduced |
| Renaissance Technologies LLC | 184,416 | $457.0K | 0.00% | +116,616+172.0% | Added |
| Driehaus Capital Management LLC | 210,074 | $521.0K | 0.01% | +174,974+498.5% | Added |
| Millennium Management LLC | 277,688 | $689.0K | 0.00% | +189,178+213.7% | Added |
| Samsara BioCapital, LLC | 289,068 | $717.0K | 0.19% | 00.0% | Unchanged |
| Armistice Capital, LLC | 323,016 | $801.0K | 0.02% | +323,016 | New |
| Vanguard Group Inc | 367,529 | $912.0K | 0.00% | −65,490−15.1% | Reduced |
| Affinity Asset Advisors, LLC | 401,268 | $995.0K | 0.54% | +401,268 | New |
| Point72 Asset Management, L.P. | 500,000 | $1.24M | 0.01% | +377,427+307.9% | Added |
| Ikarian Capital, LLC | 700,000 | $1.74M | 0.72% | +700,000 | New |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $1.77M | 0.67% | 00.0% | Unchanged |
| Antara Capital LP | 874,600 | $2.17M | 0.22% | −200,234−18.6% | Reduced |
| Suvretta Capital Management, LLC | 1,238,800 | $3.07M | 0.12% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 1,261,435 | $3.13M | 0.08% | +1,261,435 | New |
| Vivo Capital, LLC | 2,675,133 | $6.63M | 0.67% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,791,204 | $9.40M | 0.18% | 00.0% | Unchanged |
| PEAK6 Investments LLC | 14,097 | – | – | +14,097 | New |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −2,345,959−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −85,000−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −38,059−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −28,746−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −14,237−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −8,033−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −6,811−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −5,987−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,079−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,454−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −843−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −708−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −71−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |